Loading
IARC estimates 61,657 new cancer cases and 30,883 cancer deaths in Venezuela in 2024; the commonest new cancers are prostate, breast and trachea, bronchus and lung. This page is assembled automatically from OnCo's data: 1 trial with a site there, and says what OnCo does not yet hold.
Built partly from other countries' data. IARC's method code for Venezuela's incidence estimate is 3b: national mortality estimates applied to model-based mortality-to-incidence ratios (neighbouring country registry data). Read the figures as a regional estimate, not a count.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Prostate | 10,495 | 63.8 | Prostate cancer |
| Breast | 9,004 | 49.4 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Trachea, bronchus and lung | 5,249 | 13.9 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Colorectum | 4,611 | 12.7 | Colorectal cancer |
| Cervix uteri | 4,012 | 23.0 | Cervical cancer |
| Stomach | 2,330 | 6.3 | Gastric & gastro-oesophageal junction cancer |
| Non-Hodgkin lymphoma | 1,708 | 5.1 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Corpus uteri | 1,691 | 8.9 | Endometrial cancer |
| Kidney | 1,597 | 4.7 | Renal cell carcinoma |
| Leukaemia | 1,550 | 5.1 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Trachea, bronchus and lung | 4,623 | 12.5 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Prostate | 3,664 | 23.1 | Prostate cancer |
| Breast | 2,883 | 15.0 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Colorectum | 2,477 | 6.7 | Colorectal cancer |
| Cervix uteri | 2,138 | 11.6 | Cervical cancer |
| Stomach | 1,942 | 5.2 | Gastric & gastro-oesophageal junction cancer |
| Pancreas | 1,330 | 3.6 | Pancreatic ductal adenocarcinoma |
| Liver and intrahepatic bile ducts | 1,261 | 3.4 | Hepatocellular carcinoma |
| Leukaemia | 1,056 | 3.2 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Non-Hodgkin lymphoma | 784 | 2.2 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Trial | Lead sponsor | ||||
|---|---|---|---|---|---|
| Phase 3 | Active not recruiting | AstraZeneca | 106 | 2026-09-14 |
Trial records in OnCo whose ClinicalTrials.gov entry lists at least one site in Venezuela, captured 2026-10-07 to 2026-10-07. Recruiting first, then the most recently updated. The status is the study's overall status; whether a site in Venezuela is open is on the registry page, under Contacts and Locations.
OnCo holds no institution, company or person in Venezuela.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Venezuela is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
A deep dive for Venezuela is ranked 39 of 60 in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.